Posters & Publications

Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications

Elmariah et al., Journal of the American Academy of Dermatology (JAAD) International (2021)

Safety and Pharmacokinetics of Nalbuphine Following Administration of Nalbuphine ER Tablets in Subjects With Impaired Hepatic Function

Rohatagi S. et al., Poster Presentation at European Society for Dermatological Research (ESDR) 50th Annual Meeting (2021)

The Role of Kappa- and Mu- Opioid Receptors in Pruritus

as presented at Maui Derm for Dermatologists 2021

Prevalence of prurigo nodularis in the United States of America: A retrospective database analysis

Ständer et al., The American Academy of Dermatology (JAAD) International (2020)

Prevalence of Prurigo Nodularis in Poland

Reich and Ryczek, Acta Dermato Venereologica (2020)

Nalbuphine attenuates itch in the substance P-induced mouse model

as presented at 7th World Congress on Itch (2013).